GNRSU Stock Crashes 99.99% on May 4, 2026 – Greenrose Holdings Plummets

GNRSU stock has collapsed dramatically, trading at just $0.000001 USD on the OTC Pink Markets (PNK) as of May 4, 2026. The Greenrose Holding Company Inc., a medical cannabis producer based in Amityville, New York, has experienced a catastrophic 99.99% decline from its previous close of $0.15. With a market cap of only $13 and trading volume of just 145 shares, GNRSU stock represents one of the most severe distressed situations in the market. The company, which went public in February 2020, now faces existential challenges as investors flee the position entirely.

GNRSU Stock Price Collapse and Market Data

The GNRSU stock price has reached penny stock territory at $0.000001, representing a staggering drop from the year high of $0.151. Trading volume remains extremely thin at just 145 shares, indicating virtually no liquidity in the market. The current market cap of $13 is among the lowest possible valuations for any publicly traded company.

With 12.85 million shares outstanding, GNRSU stock trades on the OTC Pink Markets under the symbol GNRSU. The 50-day and 200-day moving averages both sit at $0.15, showing the stock has fallen far below historical support levels. This extreme price action suggests the company may be facing delisting or bankruptcy proceedings.

Financial Metrics and Valuation Concerns

Despite the collapsed stock price, GNRSU’s financial metrics reveal mixed signals. The company reports earnings per share (EPS) of $3.097, which would normally suggest profitability. However, the price-to-earnings ratio of 0.0000000323 indicates the market assigns virtually zero value to these earnings.

Key financial ratios show severe stress: the current ratio of 0.21 means GNRSU has only 21 cents in current assets for every dollar of current liabilities. Working capital stands at negative $103.4 million, and tangible asset value is negative $116.3 million. These metrics indicate the company is technically insolvent, with liabilities far exceeding tangible assets. Track GNRSU on Meyka for real-time updates on this distressed situation.

Cannabis Industry Operations and Business Model

Greenrose Holding Company operates in the healthcare sector, specifically in drug manufacturing for specialty and generic cannabis products. The company cultivates, processes, and packages medical cannabis and derivative products through its subsidiaries. Founded in 2014 and headquartered in Amityville, New York, the company employs 910 full-time workers.

The cannabis industry faces regulatory uncertainty and competitive pressures that may have contributed to GNRSU’s collapse. With revenue per share of $1.58 and net income per share of $1.12, the company generates some operational revenue. However, the massive debt burden and negative working capital suggest the business cannot sustain operations at current levels.

Market Sentiment and Trading Activity

Trading Activity: GNRSU stock shows virtually no trading activity, with only 145 shares changing hands. This extreme illiquidity makes it impossible for investors to exit positions at any meaningful price. The bid-ask spread is likely enormous, and any attempt to sell shares would face severe slippage.

Liquidation Concerns: The negative working capital of $103.4 million and negative tangible asset value suggest potential liquidation proceedings. Debt-to-equity ratio of 1.57 indicates the company carries substantial leverage relative to shareholder equity. With a market cap of just $13, any remaining shareholders face near-total loss of investment. The company’s ability to service debt or fund operations appears severely compromised.

Final Thoughts

GNRSU stock has collapsed 99.99% due to fundamental business failure. Greenrose Holding Company faces insolvency with negative working capital of $103.4 million and minimal liquidity. Investors should prepare for potential total loss given the company’s debt burden and negative tangible assets. The medical cannabis sector’s competitive and regulated nature, combined with GNRSU’s operational inability, indicates structural problems. This situation highlights the risks of penny stocks and OTC securities with minimal regulatory oversight and uncertain viability.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.